Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanoma
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference32 articles.
1. Value of therapeutic hyperthermic limb perfusion in advanced recurrent melanoma of the lower extremity;Storm;Am J Surg,1985
2. A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma;Minor;Cancer,1985
3. Normothermic isolation perfusion with melphalan for advanced melanoma of the limbs;Kroon;Anticancer Res,1987
4. Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion;Di Filippo;Cancer,1989
5. Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb;Skene;Br J Surg,1990
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Isolated Limb Infusion for Melanoma;Cutaneous Melanoma;2020
2. Isolated Limb Infusion for Melanoma;Cutaneous Melanoma;2018-11-23
3. Regional therapy in metastatic melanoma: an update on minimally invasive intraarterial isolated limb infusion and percutaneous hepatic perfusion;Expert Opinion on Drug Metabolism & Toxicology;2014-09
4. A Multicenter Phase I Dose Escalation Trial to Evaluate Safety and Tolerability of Intra-arterial Temozolomide for Patients with Advanced Extremity Melanoma Using Normothermic Isolated Limb Infusion;Annals of Surgical Oncology;2014-08-22
5. Quality of Life After Isolated Limb Infusion for In-Transit Melanoma of the Extremity;Annals of Surgical Oncology;2014-08-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3